Enliven Therapeutics
ELVN
ELVN
74 hedge funds and large institutions have $781M invested in Enliven Therapeutics in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
14% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 22
12.68% more ownership
Funds ownership: 94.83% → 107.51% (+13%)
Holders
74
Holding in Top 10
6
Calls
–
Puts
–
Top Buyers
| 1 | +$21.3M | |
| 2 | +$19.1M | |
| 3 | +$18.8M | |
| 4 |
CC
Commodore Capital
New York
|
+$18.8M |
| 5 |
VA
VR Adviser
New York
|
+$18.8M |
Top Sellers
| 1 | -$23.3M | |
| 2 | -$1.69M | |
| 3 | -$838K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$704K |
| 5 |
BlackRock
New York
|
-$639K |